Russell Investments Group, Ltd. Tg Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

  • $69.8 Billion
  • Q4 2024

A detailed history of Russell Investments Group, Ltd. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 34,706 shares of TGTX stock, worth $1.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,706
Previous 8,200 323.24%
Holding current value
$1.45 Million
Previous $191,000 446.6%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$21.31 - $35.09 $564,842 - $930,095
26,506 Added 323.24%
34,706 $1.04 Million
Q3 2024

Nov 13, 2024
SELL
$17.21 - $25.28 $775,413 - $1.14 Million
-45,056 Reduced 84.6%
8,200 $191,000
Q2 2024

Aug 08, 2024
BUY
$13.32 - $19.19 $12,214 - $17,597
917 Added 1.75%
53,256 $947,000
Q1 2024

May 08, 2024
BUY
$13.02 - $21.3 $389,597 - $637,359
29,923 Added 133.49%
52,339 $796,000
Q4 2023

Feb 05, 2024
SELL
$6.68 - $18.81 $10,868 - $30,603
-1,627 Reduced 6.77%
22,416 $382,000
Q3 2023

Nov 13, 2023
BUY
$8.36 - $26.5 $167,709 - $531,616
20,061 Added 503.79%
24,043 $200,000
Q2 2023

Aug 10, 2023
BUY
$15.48 - $35.0 $40,248 - $91,000
2,600 Added 188.13%
3,982 $98,000
Q1 2023

May 09, 2023
SELL
$10.23 - $19.34 $299,442 - $566,101
-29,271 Reduced 95.49%
1,382 $20,000
Q4 2022

Feb 08, 2023
BUY
$5.01 - $11.83 $27,059 - $63,893
5,401 Added 21.39%
30,653 $362,000
Q3 2022

Nov 04, 2022
BUY
$4.57 - $8.4 $115,401 - $212,116
25,252 New
25,252 $148,000
Q2 2022

Jul 29, 2022
SELL
$3.74 - $10.66 $4,334 - $12,354
-1,159 Closed
0 $0
Q1 2022

May 05, 2022
SELL
$7.81 - $20.45 $288,064 - $754,277
-36,884 Reduced 96.95%
1,159 $11,000
Q4 2021

Jan 21, 2022
SELL
$15.2 - $35.51 $149,355 - $348,921
-9,826 Reduced 20.53%
38,043 $722,000
Q3 2021

Nov 08, 2021
SELL
$21.78 - $40.45 $173,608 - $322,426
-7,971 Reduced 14.27%
47,869 $1.59 Million
Q2 2021

Aug 04, 2021
SELL
$32.5 - $48.96 $1.08 Million - $1.62 Million
-33,110 Reduced 37.22%
55,840 $2.16 Million
Q1 2021

May 10, 2021
SELL
$41.61 - $54.3 $1.54 Million - $2.01 Million
-37,013 Reduced 29.38%
88,950 $4.29 Million
Q4 2020

Feb 08, 2021
BUY
$25.27 - $54.9 $50,110 - $108,866
1,983 Added 1.6%
125,963 $6.55 Million
Q3 2020

Nov 09, 2020
BUY
$18.49 - $27.24 $2.08 Million - $3.06 Million
112,471 Added 977.24%
123,980 $3.31 Million
Q2 2020

Aug 05, 2020
BUY
$8.9 - $21.84 $102,430 - $251,356
11,509 New
11,509 $224,000
Q1 2018

May 11, 2018
SELL
$8.7 - $16.8 $114,918 - $221,911
-13,209 Closed
0 $0
Q3 2017

Nov 07, 2017
BUY
$10.0 - $12.7 $132,090 - $167,754
13,209
13,209 $157,000

Others Institutions Holding TGTX

# of Institutions
373
Shares Held
85.5M
Call Options Held
3.78M
Put Options Held
3M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $6.09B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email